US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CytoMed Therapeutics Limited

0.8000

+0.00530.67%

Volume:4K

Turnover:3.61K

Market Cap:9.46M

PE:-3.01

High:0.8500

Open:0.8500

Low:0.8000

Close:0.7947

52wk High:3.68

52wk Low:0.6801

Shares:11.83M

Float Shares:3.49M

Volume Ratio:0.87

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.2657

EPS(LYR):-0.2657

ROE:-50.28%

ROA:-29.31%

PB:1.83

PE(LYR):-3.01

Loading ...

Overview Company News Filings

Cytomed Director, 10% Owner Choo Chee Kong Acquires $300,000 in Common Shares

Cytomed director, 10% owner Choo Chee Kong buys $128,778 of common shares

CytoMed Therapeutics shareholders approve US$ 70,000 director fee payout plan for 2026

Cytomed Therapeutics director Toh Keng Kiat files initial beneficial ownership statement

Cytomed Therapeutics director Yew Chak Hua files initial beneficial ownership statement

CytoMed Therapeutics director Mark Kei Wei Leong files initial beneficial ownership statement

CytoMed Therapeutics CFO Yvonne Goh files initial beneficial ownership statement

Cytomed chairman Choo buys 112,000 shares in private deal

Cytomed unit Advance Cancer Centre rebrands as CytoMed International

Cytomed Therapeutics announces annual shareholder meeting

Cytomed net loss widens to S$4 million in FY25

CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/GDTC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GDTC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GDTC\",,,,,undefined,":{"symbol":"GDTC","market":"US","secType":"STK","nameCN":"CytoMed Therapeutics Limited","latestPrice":0.8,"timestamp":1789056603502,"preClose":0.7947,"halted":0,"volume":4497,"delay":0,"changeRate":0.00666918333962512,"floatShares":3494300,"shares":11828435,"eps":-0.2657,"marketStatus":"Trading","change":0.0053,"latestTime":"09-10 12:18:32 EDT","open":0.85,"high":0.85,"low":0.8,"amount":3613.7334372,"amplitude":0.062917,"askPrice":0.85,"askSize":700,"bidPrice":0.77,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":-0.2657,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1681444800000,"exchange":"NASDAQ","adjPreClose":0.7947,"postHourTrading":{"tag":"盘后","latestPrice":0.8106,"preClose":0.7947,"latestTime":"16:13 EDT","volume":154,"amount":125.7063,"timestamp":1788984796928,"change":0.0159,"changeRate":0.020008,"amplitude":0},"volumeRatio":0.873014},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GDTC\",,,,,undefined,":{"symbol":"GDTC","floatShares":3494300,"roa":"-29.31%","roe":"-50.28%","lyrEps":-0.2657,"volumeRatio":0.873014,"shares":11828435,"dividePrice":0,"high":0.85,"amplitude":0.062917,"preClose":0.7947,"low":0.8,"week52Low":0.6801,"pbRate":"1.83","psRate":"13.93","week52High":3.68,"institutionHeld":0,"latestPrice":0.8,"committee":0.5625,"eps":-0.2657,"divideRate":0,"volume":4497,"delay":0,"ttmEps":-0.2657,"open":0.85,"prevYearClose":1.335,"prevWeekClose":0.8611,"prevMonthClose":0.9087,"prevQuarterClose":1.03,"fiveDayClose":0.88,"twentyDayClose":0.8085,"sixtyDayClose":1.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GDTC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-31","symbol":"GDTC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":null},{"date":"2025-09-30","symbol":"GDTC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1759219200000,"name":null,"time":"Pre-MKt","dateTimestamp":1759204800000,"actualEps":null},{"market":"US","date":"2025-04-28","symbol":"GDTC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1745812800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-10-08","symbol":"GDTC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1728360000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GDTC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GDTC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GDTC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GDTC","date":"2026-09-09","current":-3.010915,"percent":0.981796,"low":-32.187359,"twenty":-14.164251,"median":-10.972884,"eighty":-5.264044,"high":-2.723253,"avg":-10.517815,"sd":5.17982,"marketCap":10294566},"quantilePoints":[{"date":"2023-04-14","current":-32.187359,"twenty":-32.187359,"median":-32.187359,"eighty":-32.187359,"marketCap":49229185},{"date":"2023-04-21","current":-23.996859,"twenty":-28.890857,"median":-26.696093,"eighty":-25.221924,"marketCap":36429597},{"date":"2023-04-28","current":-25.0053,"twenty":-27.115492,"median":-25.0053,"eighty":-23.900672,"marketCap":37847397},{"date":"2023-05-05","current":-17.068346,"twenty":-26.444454,"median":-24.364194,"eighty":-23.760246,"marketCap":40232278},{"date":"2023-05-12","current":-13.070634,"twenty":-25.432878,"median":-23.948766,"eighty":-17.250936,"marketCap":30740891},{"date":"2023-05-19","current":-13.942715,"twenty":-25.048625,"median":-23.457114,"eighty":-14.326746,"marketCap":32381864},{"date":"2023-05-26","current":-13.013489,"twenty":-24.831622,"median":-17.395,"eighty":-13.746669,"marketCap":30084502},{"date":"2023-06-02","current":-13.452888,"twenty":-24.533797,"median":-16.759279,"eighty":-13.607683,"marketCap":31244478},{"date":"2023-06-07","current":-13.846324,"twenty":-24.335541,"median":-14.413802,"eighty":-13.619509,"marketCap":32166825},{"date":"2023-06-16","current":-13.983516,"twenty":-24.176114,"median":-14.413777,"eighty":-13.645416,"marketCap":32743291},{"date":"2023-06-23","current":-14.403184,"twenty":-23.996859,"median":-14.329877,"eighty":-13.648316,"marketCap":33550344},{"date":"2023-06-30","current":-15.414863,"twenty":-23.919909,"median":-14.329877,"eighty":-13.682012,"marketCap":35626776},{"date":"2023-07-07","current":-16.268645,"twenty":-23.861886,"median":-14.413777,"eighty":-13.732611,"marketCap":37585609},{"date":"2023-07-14","current":-21.482937,"twenty":-23.861886,"median":-15.213534,"eighty":-13.784206,"marketCap":50844336},{"date":"2023-07-21","current":-18.816327,"twenty":-23.60868,"median":-15.364674,"eighty":-13.827738,"marketCap":44387912},{"date":"2023-07-28","current":-19.927212,"twenty":-22.272608,"median":-15.785661,"eighty":-13.849589,"marketCap":46924364},{"date":"2023-08-04","current":-20.727324,"twenty":-21.444799,"median":-16.359428,"eighty":-13.855946,"marketCap":48423177},{"date":"2023-08-11","current":-20.483755,"twenty":-21.444799,"median":-17.251819,"eighty":-13.870774,"marketCap":47616124},{"date":"2023-08-18","current":-19.114176,"twenty":-21.359469,"median":-17.475439,"eighty":-13.917149,"marketCap":44042032},{"date":"2023-08-25","current":-16.863134,"twenty":-21.233742,"median":-17.849445,"eighty":-13.94778,"marketCap":38969128},{"date":"2023-09-01","current":-16.79246,"twenty":-21.145427,"median":-17.441381,"eighty":-13.967696,"marketCap":38917246},{"date":"2023-09-08","current":-17.041842,"twenty":-21.112661,"median":-17.432432,"eighty":-13.98064,"marketCap":39084421},{"date":"2023-09-15","current":-18.059224,"twenty":-21.060627,"median":-17.448514,"eighty":-14.024429,"marketCap":41505580},{"date":"2023-09-22","current":-18.116195,"twenty":-20.905866,"median":-17.493416,"eighty":-14.200663,"marketCap":41506733},{"date":"2023-09-29","current":-17.671976,"twenty":-20.821633,"median":-17.637629,"eighty":-14.251467,"marketCap":40467941},{"date":"2023-10-06","current":-18.352226,"twenty":-20.772997,"median":-17.686193,"eighty":-14.254026,"marketCap":41966753},{"date":"2023-10-13","current":-17.809938,"twenty":-20.67861,"median":-17.679085,"eighty":-14.285893,"marketCap":40738880},{"date":"2023-10-20","current":-16.930791,"twenty":-20.479432,"median":-17.671976,"eighty":-14.405298,"marketCap":38622095},{"date":"2023-10-27","current":-17.724189,"twenty":-20.470787,"median":-17.686193,"eighty":-14.409525,"marketCap":40467941},{"date":"2023-11-03","current":-19.557394,"twenty":-20.426928,"median":-17.699338,"eighty":-14.413782,"marketCap":44849085},{"date":"2023-11-10","current":-19.779409,"twenty":-20.426928,"median":-17.758237,"eighty":-14.577325,"marketCap":45656138},{"date":"2023-11-17","current":-20.199358,"twenty":-20.400538,"median":-17.829691,"eighty":-15.002657,"marketCap":46924364},{"date":"2023-11-24","current":-13.288871,"twenty":-20.365537,"median":-17.770523,"eighty":-14.407411,"marketCap":42543220},{"date":"2023-12-01","current":-13.234082,"twenty":-20.295603,"median":-17.712483,"eighty":-14.213244,"marketCap":42543220},{"date":"2023-12-08","current":-12.420365,"twenty":-20.261217,"median":-17.662803,"eighty":-13.946092,"marketCap":39826910},{"date":"2023-12-15","current":-11.641369,"twenty":-20.239107,"median":-17.621628,"eighty":-13.848501,"marketCap":37700902},{"date":"2023-12-22","current":-15.355974,"twenty":-20.208527,"median":-17.491329,"eighty":-13.818445,"marketCap":49691403},{"date":"2023-12-29","current":-18.408812,"twenty":-20.199358,"median":-17.49058,"eighty":-13.846324,"marketCap":59952505},{"date":"2024-01-05","current":-15.523017,"twenty":-20.173796,"median":-17.483753,"eighty":-13.849589,"marketCap":50152576},{"date":"2024-01-12","current":-15.504777,"twenty":-20.143787,"median":-17.439566,"eighty":-13.855946,"marketCap":49921990},{"date":"2024-01-19","current":-13.786478,"twenty":-20.098931,"median":-17.372527,"eighty":-13.854553,"marketCap":44042032},{"date":"2024-01-26","current":-13.753965,"twenty":-19.997652,"median":-17.329203,"eighty":-13.854553,"marketCap":44042032},{"date":"2024-02-02","current":-12.568738,"twenty":-19.916959,"median":-17.192655,"eighty":-13.771027,"marketCap":40351495},{"date":"2024-02-09","current":-8.105087,"twenty":-19.852711,"median":-17.147281,"eighty":-13.646141,"marketCap":25825694},{"date":"2024-02-16","current":-9.076446,"twenty":-19.753496,"median":-17.068346,"eighty":-13.40372,"marketCap":28938613},{"date":"2024-02-23","current":-8.044355,"twenty":-19.710912,"median":-17.041842,"eighty":-13.347563,"marketCap":25710401},{"date":"2024-03-01","current":-7.261373,"twenty":-19.668319,"median":-16.896963,"eighty":-13.264875,"marketCap":23173949},{"date":"2024-03-08","current":-7.340929,"twenty":-19.557394,"median":-16.450211,"eighty":-13.126445,"marketCap":23635122},{"date":"2024-03-15","current":-7.674245,"twenty":-19.513851,"median":-16.233519,"eighty":-13.055436,"marketCap":24672761},{"date":"2024-03-22","current":-8.225396,"twenty":-19.294578,"median":-15.795176,"eighty":-12.699525,"marketCap":26286867},{"date":"2024-03-28","current":-8.115312,"twenty":-19.114176,"median":-15.75403,"eighty":-12.579008,"marketCap":25825694},{"date":"2024-04-05","current":-7.410887,"twenty":-19.082247,"median":-15.513897,"eighty":-12.420365,"marketCap":23635122},{"date":"2024-04-12","current":-7.65753,"twenty":-18.941307,"median":-15.414863,"eighty":-11.641369,"marketCap":24269235},{"date":"2024-04-19","current":-7.636297,"twenty":-18.852191,"median":-15.302207,"eighty":-9.130689,"marketCap":24096295},{"date":"2024-04-26","current":-8.357058,"twenty":-18.838972,"median":-15.213534,"eighty":-8.980148,"marketCap":25388000},{"date":"2024-05-03","current":-7.962415,"twenty":-18.827004,"median":-15.042386,"eighty":-8.543858,"marketCap":24234000},{"date":"2024-05-10","current":-8.019464,"twenty":-18.816327,"median":-14.686341,"eighty":-8.394768,"marketCap":24487880},{"date":"2024-05-17","current":-8.003724,"twenty":-18.67885,"median":-14.413777,"eighty":-8.168989,"marketCap":24580200},{"date":"2024-05-24","current":-7.621351,"twenty":-18.609148,"median":-14.274039,"eighty":-8.138739,"marketCap":23310800},{"date":"2024-05-31","current":-7.573126,"twenty":-18.591233,"median":-14.25339,"eighty":-8.112764,"marketCap":23195400},{"date":"2024-06-07","current":-7.781706,"twenty":-18.580215,"median":-14.149686,"eighty":-8.062992,"marketCap":23886646},{"date":"2024-06-14","current":-7.763239,"twenty":-18.476719,"median":-14.065397,"eighty":-8.040579,"marketCap":23772400},{"date":"2024-06-21","current":-7.258799,"twenty":-18.395516,"median":-13.981119,"eighty":-8.003519,"marketCap":22156800},{"date":"2024-06-28","current":-7.70107,"twenty":-18.382221,"median":-13.96648,"eighty":-7.975269,"marketCap":23430816},{"date":"2024-07-05","current":-7.696127,"twenty":-18.361565,"median":-13.946936,"eighty":-7.947287,"marketCap":23541600},{"date":"2024-07-12","current":-7.684396,"twenty":-18.314998,"median":-13.858733,"eighty":-7.939183,"marketCap":23657000},{"date":"2024-07-15","current":-7.608577,"twenty":-18.302589,"median":-13.855249,"eighty":-7.925519,"marketCap":23426200},{"date":"2024-08-02","current":-6.534197,"twenty":-18.29018,"median":-13.851766,"eighty":-7.898651,"marketCap":20195000},{"date":"2024-08-09","current":-6.59149,"twenty":-18.236861,"median":-13.793169,"eighty":-7.838233,"marketCap":20541200},{"date":"2024-08-16","current":-6.378946,"twenty":-18.219132,"median":-13.753965,"eighty":-7.780156,"marketCap":19964200},{"date":"2024-08-23","current":-5.853677,"twenty":-18.134107,"median":-13.646503,"eighty":-7.759668,"marketCap":18464000},{"date":"2024-08-30","current":-5.279227,"twenty":-18.116195,"median":-13.552172,"eighty":-7.70107,"marketCap":16733000},{"date":"2024-09-06","current":-5.41733,"twenty":-18.115793,"median":-13.370941,"eighty":-7.683775,"marketCap":17194600},{"date":"2024-09-13","current":-5.428022,"twenty":-18.095282,"median":-13.351778,"eighty":-7.658912,"marketCap":17194600},{"date":"2024-09-20","current":-5.595314,"twenty":-18.088626,"median":-13.288871,"eighty":-7.633823,"marketCap":17887000},{"date":"2024-09-27","current":-5.304149,"twenty":-18.065027,"median":-13.255069,"eighty":-7.6083,"marketCap":17079200},{"date":"2024-10-04","current":-8.621532,"twenty":-17.980434,"median":-13.209908,"eighty":-7.604577,"marketCap":20353098},{"date":"2024-10-11","current":-9.901703,"twenty":-17.910917,"median":-13.087276,"eighty":-7.6083,"marketCap":23195400},{"date":"2024-10-18","current":-10.541651,"twenty":-17.892717,"median":-13.052108,"eighty":-7.615004,"marketCap":24581354},{"date":"2024-10-25","current":-15.069135,"twenty":-17.857812,"median":-13.032799,"eighty":-7.620403,"marketCap":34966200},{"date":"2024-10-31","current":-11.088307,"twenty":-17.825741,"median":-12.896116,"eighty":-7.625215,"marketCap":25683424},{"date":"2024-11-08","current":-12.649628,"twenty":-17.793661,"median":-12.776012,"eighty":-7.632315,"marketCap":29311600},{"date":"2024-11-15","current":-10.716333,"twenty":-17.768066,"median":-12.687238,"eighty":-7.635911,"marketCap":24464800},{"date":"2024-11-22","current":-11.15139,"twenty":-17.737808,"median":-12.650128,"eighty":-7.643199,"marketCap":25388000},{"date":"2024-11-29","current":-11.887986,"twenty":-17.719507,"median":-12.579008,"eighty":-7.651693,"marketCap":27119000},{"date":"2024-12-06","current":-14.681291,"twenty":-17.701967,"median":-12.573873,"eighty":-7.658221,"marketCap":33581400},{"date":"2024-12-13","current":-13.732197,"twenty":-17.680506,"median":-12.650128,"eighty":-7.66504,"marketCap":31273400},{"date":"2024-12-20","current":-12.503123,"twenty":-17.664638,"median":-12.653754,"eighty":-7.673925,"marketCap":28157600},{"date":"2024-12-27","current":-14.317736,"twenty":-17.651044,"median":-12.687238,"eighty":-7.675654,"marketCap":32276226},{"date":"2025-01-03","current":-18.055457,"twenty":-17.65363,"median":-12.744378,"eighty":-7.681291,"marketCap":40390000},{"date":"2025-01-10","current":-11.811271,"twenty":-17.657299,"median":-12.777378,"eighty":-7.683775,"marketCap":26426600},{"date":"2025-01-17","current":-12.301565,"twenty":-17.643286,"median":-12.712745,"eighty":-7.687173,"marketCap":27580600},{"date":"2025-01-24","current":-12.618326,"twenty":-17.632572,"median":-12.69622,"eighty":-7.692823,"marketCap":28503800},{"date":"2025-01-31","current":-13.164329,"twenty":-17.623838,"median":-12.704483,"eighty":-7.699093,"marketCap":29888600},{"date":"2025-02-07","current":-14.353547,"twenty":-17.572403,"median":-12.778743,"eighty":-7.704188,"marketCap":32542800},{"date":"2025-02-14","current":-12.677025,"twenty":-17.530008,"median":-12.98759,"eighty":-7.733689,"marketCap":28850000},{"date":"2025-02-21","current":-13.835636,"twenty":-17.51154,"median":-13.012667,"eighty":-7.754009,"marketCap":31735000},{"date":"2025-02-28","current":-14.210189,"twenty":-17.492282,"median":-13.052108,"eighty":-7.758106,"marketCap":32312000},{"date":"2025-03-07","current":-13.937974,"twenty":-17.490045,"median":-13.082373,"eighty":-7.761096,"marketCap":32081200},{"date":"2025-03-14","current":-13.430529,"twenty":-17.48485,"median":-13.094112,"eighty":-7.766851,"marketCap":30811800},{"date":"2025-03-21","current":-13.383835,"twenty":-17.469943,"median":-13.100143,"eighty":-7.774553,"marketCap":30696400},{"date":"2025-03-28","current":-11.347106,"twenty":-17.450304,"median":-13.096368,"eighty":-7.778849,"marketCap":25965000},{"date":"2025-04-04","current":-12.036679,"twenty":-17.433859,"median":-13.074526,"eighty":-7.780776,"marketCap":27638300},{"date":"2025-04-11","current":-12.537352,"twenty":-17.40419,"median":-13.068746,"eighty":-7.789167,"marketCap":28850000},{"date":"2025-04-17","current":-11.507236,"twenty":-17.370437,"median":-13.052108,"eighty":-7.801638,"marketCap":26888200},{"date":"2025-04-25","current":-11.618406,"twenty":-17.362024,"median":-13.012667,"eighty":-7.813051,"marketCap":27119000},{"date":"2025-05-02","current":-13.832921,"twenty":-17.348774,"median":-13.013489,"eighty":-7.845017,"marketCap":26542000},{"date":"2025-05-09","current":-13.68949,"twenty":-17.287631,"median":-13.057676,"eighty":-7.87455,"marketCap":26542000},{"date":"2025-05-16","current":-13.868797,"twenty":-17.239986,"median":-13.070634,"eighty":-7.884698,"marketCap":26888200},{"date":"2025-05-23","current":-13.322458,"twenty":-17.187034,"median":-13.074526,"eighty":-7.889275,"marketCap":25965000},{"date":"2025-05-30","current":-13.687893,"twenty":-17.16455,"median":-13.086265,"eighty":-7.898651,"marketCap":26772800},{"date":"2025-06-06","current":-11.908459,"twenty":-17.160716,"median":-13.078418,"eighty":-7.932236,"marketCap":23310800},{"date":"2025-06-13","current":-12.526503,"twenty":-17.133847,"median":-13.065995,"eighty":-7.943814,"marketCap":24637900},{"date":"2025-06-20","current":-13.772748,"twenty":-17.086739,"median":-13.057676,"eighty":-7.948445,"marketCap":26888200},{"date":"2025-06-27","current":-13.442284,"twenty":-17.069669,"median":-13.068746,"eighty":-7.959853,"marketCap":26542000},{"date":"2025-07-03","current":-12.84526,"twenty":-17.062326,"median":-13.068746,"eighty":-7.969734,"marketCap":25369536},{"date":"2025-07-11","current":-12.919472,"twenty":-17.04843,"median":-13.065995,"eighty":-7.975105,"marketCap":25388000},{"date":"2025-07-18","current":-11.970391,"twenty":-17.036468,"median":-13.047615,"eighty":-7.978113,"marketCap":23426200},{"date":"2025-07-25","current":-11.1234,"twenty":-16.971629,"median":-13.019911,"eighty":-7.991875,"marketCap":21926000},{"date":"2025-08-01","current":-11.187429,"twenty":-16.890197,"median":-12.997048,"eighty":-8.001973,"marketCap":21695200},{"date":"2025-08-08","current":-10.961291,"twenty":-16.82073,"median":-12.950122,"eighty":-8.003587,"marketCap":21464400},{"date":"2025-08-15","current":-10.507317,"twenty":-16.587111,"median":-12.881751,"eighty":-8.010941,"marketCap":20587360},{"date":"2025-08-22","current":-10.51661,"twenty":-16.341271,"median":-12.777378,"eighty":-8.01798,"marketCap":20541200},{"date":"2025-08-29","current":-11.76616,"twenty":-16.252726,"median":-12.726567,"eighty":-8.028735,"marketCap":23080000},{"date":"2025-09-05","current":-11.240492,"twenty":-16.235238,"median":-12.69622,"eighty":-8.038691,"marketCap":21926000},{"date":"2025-09-12","current":-11.811257,"twenty":-16.218885,"median":-12.674689,"eighty":-8.045093,"marketCap":23195400},{"date":"2025-09-19","current":-11.053208,"twenty":-16.143284,"median":-12.664496,"eighty":-8.048004,"marketCap":21695200},{"date":"2025-09-26","current":-11.68813,"twenty":-15.944154,"median":-12.649878,"eighty":-8.054123,"marketCap":22733800},{"date":"2025-10-03","current":-8.151484,"twenty":-15.79137,"median":-12.618326,"eighty":-8.058905,"marketCap":23195400},{"date":"2025-10-10","current":-9.191333,"twenty":-15.773009,"median":-12.573873,"eighty":-8.061972,"marketCap":25965000},{"date":"2025-10-17","current":-9.15018,"twenty":-15.7494,"median":-12.537352,"eighty":-8.061972,"marketCap":25965000},{"date":"2025-10-24","current":-9.919614,"twenty":-15.718039,"median":-12.519457,"eighty":-8.081673,"marketCap":28042200},{"date":"2025-10-31","current":-8.788032,"twenty":-15.618055,"median":-12.473628,"eighty":-8.106053,"marketCap":24811000},{"date":"2025-11-07","current":-8.367389,"twenty":-15.515721,"median":-12.427329,"eighty":-8.110133,"marketCap":23541600},{"date":"2025-11-14","current":-7.839227,"twenty":-15.484129,"median":-12.317266,"eighty":-8.058905,"marketCap":22156800},{"date":"2025-11-21","current":-7.393794,"twenty":-15.43784,"median":-12.304305,"eighty":-8.051614,"marketCap":20772000},{"date":"2025-11-28","current":-7.499871,"twenty":-15.403085,"median":-12.290011,"eighty":-8.036803,"marketCap":21233600},{"date":"2025-12-05","current":-7.530923,"twenty":-15.347676,"median":-12.246344,"eighty":-8.00613,"marketCap":21349000},{"date":"2025-12-12","current":-6.777454,"twenty":-15.309573,"median":-12.141625,"eighty":-7.976326,"marketCap":19271800},{"date":"2025-12-19","current":-6.320053,"twenty":-15.285071,"median":-12.121967,"eighty":-7.952165,"marketCap":18002400},{"date":"2025-12-26","current":-6.211198,"twenty":-15.265632,"median":-12.113423,"eighty":-7.898651,"marketCap":17771600},{"date":"2026-01-02","current":-5.395333,"twenty":-15.224986,"median":-12.083343,"eighty":-7.882532,"marketCap":15405900},{"date":"2026-01-09","current":-5.291457,"twenty":-15.213792,"median":-12.061574,"eighty":-7.833207,"marketCap":15117400},{"date":"2026-01-16","current":-3.764422,"twenty":-15.190549,"median":-12.044113,"eighty":-7.781396,"marketCap":10732200},{"date":"2026-01-23","current":-3.826015,"twenty":-15.147218,"median":-11.990216,"eighty":-7.768658,"marketCap":10964154},{"date":"2026-01-30","current":-3.347404,"twenty":-15.090345,"median":-11.944017,"eighty":-7.748526,"marketCap":9708602},{"date":"2026-02-06","current":-4.322372,"twenty":-15.005221,"median":-11.908459,"eighty":-7.699986,"marketCap":12463200},{"date":"2026-02-13","current":-3.75647,"twenty":-14.907386,"median":-11.885409,"eighty":-7.683154,"marketCap":10927226},{"date":"2026-02-20","current":-4.10624,"twenty":-14.847868,"median":-11.873202,"eighty":-7.66504,"marketCap":11886200},{"date":"2026-02-27","current":-4.291214,"twenty":-14.772227,"median":-11.851773,"eighty":-7.635717,"marketCap":12463200},{"date":"2026-03-06","current":-4.188071,"twenty":-14.700441,"median":-11.828841,"eighty":-7.611791,"marketCap":12001600},{"date":"2026-03-13","current":-4.297785,"twenty":-14.684321,"median":-11.811271,"eighty":-7.574943,"marketCap":12347800},{"date":"2026-03-20","current":-4.223392,"twenty":-14.65862,"median":-11.766948,"eighty":-7.56109,"marketCap":12117000},{"date":"2026-03-27","current":-4.159455,"twenty":-14.622949,"median":-11.719587,"eighty":-7.512292,"marketCap":11886200},{"date":"2026-04-02","current":-3.836503,"twenty":-14.619992,"median":-11.656712,"eighty":-7.485562,"marketCap":11886200},{"date":"2026-04-10","current":-3.785258,"twenty":-14.589823,"median":-11.64444,"eighty":-7.411183,"marketCap":11828435},{"date":"2026-04-17","current":-3.857903,"twenty":-14.463984,"median":-11.631401,"eighty":-7.402057,"marketCap":12065003},{"date":"2026-04-24","current":-3.829758,"twenty":-14.413792,"median":-11.606427,"eighty":-7.369494,"marketCap":11951163},{"date":"2026-05-01","current":-3.775662,"twenty":-14.411638,"median":-11.574695,"eighty":-7.26842,"marketCap":11797336},{"date":"2026-05-08","current":-2.723253,"twenty":-14.393257,"median":-11.543248,"eighty":-7.22341,"marketCap":8557506},{"date":"2026-05-15","current":-3.335745,"twenty":-14.351815,"median":-11.520402,"eighty":-6.836699,"marketCap":10415261},{"date":"2026-05-22","current":-4.642655,"twenty":-14.339813,"median":-11.485005,"eighty":-6.596817,"marketCap":14436058},{"date":"2026-05-29","current":-4.324967,"twenty":-14.319518,"median":-11.450591,"eighty":-6.531825,"marketCap":13489431},{"date":"2026-06-05","current":-4.503451,"twenty":-14.317736,"median":-11.389658,"eighty":-6.352427,"marketCap":13962745},{"date":"2026-06-12","current":-4.098651,"twenty":-14.279504,"median":-11.352673,"eighty":-6.308669,"marketCap":12661133},{"date":"2026-06-18","current":-4.140166,"twenty":-14.275132,"median":-11.280966,"eighty":-6.191966,"marketCap":12779461},{"date":"2026-06-26","current":-3.811927,"twenty":-14.273532,"median":-11.270857,"eighty":-6.070841,"marketCap":11714506},{"date":"2026-07-02","current":-3.800362,"twenty":-14.266568,"median":-11.241832,"eighty":-5.842133,"marketCap":11715689},{"date":"2026-07-10","current":-3.765528,"twenty":-14.258746,"median":-11.221486,"eighty":-5.78248,"marketCap":11596178},{"date":"2026-07-17","current":-3.913068,"twenty":-14.254982,"median":-11.187429,"eighty":-5.703894,"marketCap":12069491},{"date":"2026-07-24","current":-3.382756,"twenty":-14.253603,"median":-11.147599,"eighty":-5.631826,"marketCap":10412894},{"date":"2026-07-31","current":-3.773323,"twenty":-14.252428,"median":-11.124921,"eighty":-5.597402,"marketCap":11707406},{"date":"2026-08-07","current":-3.063347,"twenty":-14.24002,"median":-11.071219,"eighty":-5.503243,"marketCap":9500583},{"date":"2026-08-14","current":-3.216488,"twenty":-14.218218,"median":-11.053208,"eighty":-5.427966,"marketCap":9998745},{"date":"2026-08-21","current":-3.398415,"twenty":-14.201346,"median":-11.031506,"eighty":-5.415053,"marketCap":10637718},{"date":"2026-08-28","current":-3.58985,"twenty":-14.18625,"median":-11.002907,"eighty":-5.356994,"marketCap":11241193},{"date":"2026-09-04","current":-3.313561,"twenty":-14.173876,"median":-10.98014,"eighty":-5.277648,"marketCap":10412314},{"date":"2026-09-09","current":-3.270296,"twenty":-14.164251,"median":-10.972884,"eighty":-5.264044,"marketCap":10294566}],"updateTime":1789057112933},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GDTC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654036493","title":"Cytomed Director, 10% Owner Choo Chee Kong Acquires $300,000 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2654036493","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654036493?lang=en_us&edition=fundamental","pubTime":"2026-07-25 00:34","pubTimestamp":1784910866,"startTime":"0","endTime":"0","summary":"Cytomed director, 10% owner Choo Chee Kong acquires $300,000 in common sharesCytomed Therapeutics: Director and 10% owner Choo Chee Kong disclosed sales of 200,000 ordinary shares at USD 1.5 each.Dire","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL2nCKZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cytomed Director, 10% Owner Choo Chee Kong Acquires $300,000 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GDTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643721012","title":"Cytomed director, 10% owner Choo Chee Kong buys $128,778 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2643721012","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643721012?lang=en_us&edition=fundamental","pubTime":"2026-06-15 18:16","pubTimestamp":1781518576,"startTime":"0","endTime":"0","summary":"Cytomed Therapeutics director Choo Chee Kong bought 112,000 ordinary shares at USD 1.15 each, a Form 4 filing showed.His direct holding rose to 430,324 ordinary shares following the purchase.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL3D4flk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cytomed director, 10% owner Choo Chee Kong buys $128,778 of common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640582181","title":"CytoMed Therapeutics shareholders approve US$ 70,000 director fee payout plan for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640582181","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640582181?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:10","pubTimestamp":1780517416,"startTime":"0","endTime":"0","summary":"Cytomed Therapeutics held its annual shareholder meeting on May 22, 2026.Shareholders adopted the directors’ statement and audited financial statements for the year ended Dec. 31, 2025.They adopted the audited financial statements included in the company’s Form 20-F for the same period.They endorsed a waiver tied to Singapore’s take-over and mergers code.They authorized the board to issue ordinary shares and granted authority to adjourn the meeting if needed to secure approvals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL9scypf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638178015","title":"Cytomed Therapeutics director Toh Keng Kiat files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2638178015","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638178015?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:00","pubTimestamp":1779800452,"startTime":"0","endTime":"0","summary":"CytoMed Therapeutics director Toh Keng Kiat reported direct ownership of 4,000 ordinary shares in an initial SEC Form 3 filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL60ztBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GDTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087391","title":"Cytomed Therapeutics director Yew Chak Hua files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087391","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087391?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:02","pubTimestamp":1778850120,"startTime":"0","endTime":"0","summary":"CytoMed Therapeutics director Yew Chak Hua reported direct ownership of 2,469 ordinary shares in an initial Form 3 filing dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLc4sGmc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GDTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635873500","title":"CytoMed Therapeutics director Mark Kei Wei Leong files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2635873500","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635873500?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:01","pubTimestamp":1778850117,"startTime":"0","endTime":"0","summary":"Cytomed Therapeutics filed an initial Form 3 disclosing director Mark Kei Wei Leong as a reporting insider, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLYw58H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GDTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635087362","title":"CytoMed Therapeutics CFO Yvonne Goh files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2635087362","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635087362?lang=en_us&edition=fundamental","pubTime":"2026-05-15 21:01","pubTimestamp":1778850100,"startTime":"0","endTime":"0","summary":"CytoMed Therapeutics CFO Yvonne Goh reported direct ownership of 25,781 ordinary shares in an initial Form 3 filing dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL8Fc8Rc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GDTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081242","title":"Cytomed chairman Choo buys 112,000 shares in private deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081242","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081242?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:03","pubTimestamp":1778846592,"startTime":"0","endTime":"0","summary":"Chairman Choo Chee Kong agreed May 13, 2026 to buy 112,000 ordinary shares in Cytomed Therapeutics in a private, cash deal with an independent shareholder.Company was not a party to the transaction, received no proceeds.Choo plans further private purchases to increase his stake.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLg3z4T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634157286","title":"Cytomed unit Advance Cancer Centre rebrands as CytoMed International","url":"https://stock-news.laohu8.com/highlight/detail?id=2634157286","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634157286?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:01","pubTimestamp":1778500912,"startTime":"0","endTime":"0","summary":"Cytomed Therapeutics renamed wholly owned unit Advance Cancer Centre to CytoMed International, effective May 6, 2026.Rebranded unit to serve as vehicle for international expansion, with initial focus on Asia, particularly China.CytoMed International’s only asset is a 19% stake in a licensed clinic in Malaysia, with an option to raise its holding.Name change leaves legal entity, ownership structure, contractual obligations unchanged.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 11, 2026, and is solely responsib","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLZkRPt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDTC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627421265","title":"Cytomed Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2627421265","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627421265?lang=en_us&edition=fundamental","pubTime":"2026-04-15 04:20","pubTimestamp":1776198014,"startTime":"0","endTime":"0","summary":"CytoMed Therapeutics will hold its annual general meeting in Singapore on May 22, 2026.Shareholders will vote on adoption of audited financial statements for fiscal 2025, including statements filed with its Form 20-F.Ballots will also cover re-election of two directors, plus a waiver related to takeover rules.Other items include ratification of two auditor appointments for 2026, approval of US$ 70,000 in directors’ fees for 2026.Meeting will also seek authority for directors to issue new ordinary shares, including shares tied to follow-on offerings and equity-linked instruments.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260414:nNDL7sDh5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GDTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624553649","title":"Cytomed net loss widens to S$4 million in FY25","url":"https://stock-news.laohu8.com/highlight/detail?id=2624553649","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624553649?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:12","pubTimestamp":1774991561,"startTime":"0","endTime":"0","summary":"Cytomed Therapeutics posted a net loss of S$4 million for fiscal 2025.Revenue rose to S$324,387, driven mainly by private blood banking services.Net cash used in operating activities widened to S$3.7 million.Cash and bank balances fell to S$2.1 million at year-end.ANGELICA Phase I trial of lead candidate CTM-N2D remained ongoing, with continued patient recruitment expected in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytomed Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL24rF7R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GDTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606710757","title":"CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2606710757","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606710757?lang=en_us&edition=fundamental","pubTime":"2026-01-28 23:00","pubTimestamp":1769612417,"startTime":"0","endTime":"0","summary":"CytoMed Therapeutics Ltd. has issued a statement refuting recent inaccurate and misleading claims about its research programs, clinical progress, and operations. The company clarified that its scientific focus, development status, and regulatory standing have been mischaracterized by certain public statements. CytoMed emphasized that its lead CAR γδ T cell therapy has regulatory approval for a first-in-human clinical trial currently underway at National University Hospital in Singapore, conducted under appropriate regulatory and ethical guidelines. The company also noted that other programs, such as iPSC-derived γδ NKT cell therapies, remain in preclinical development and are not approved for commercial use. CytoMed reaffirmed its commitment to accurate communication and compliance with applicable regulations, and reserved the right to address the spread of false or misleading information.Disclaimer: This news brief was created by Public Technologies  using generative artificial intell","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDLM0dWy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4139","BK4112","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP","SG9999014039.USD","GDTC","LU0314104364.USD","BK4585","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}